Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · April 30, 2023

Safety and Effectiveness of Adalimumab Combined With Methotrexate vs Adalimumab Monotherapy in Patients With Psoriasis

Journal of the European Academy of Dermatology and Venereology: JEADV


Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial
J Eur Acad Dermatol Venereol 2023 Apr 04;[EPub Ahead of Print], AM van Huizen, GE van der Kraaij, CI Busard, W Ouwerkerk, JMPA van den Reek, SP Menting, EP Prens, T Rispens, A de Vries, EMGJ de Jong, J Lambert, MBA van Doorn, PI Spuls

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading